Europe Hungary English Deutch Romanian

www.NPCRIZ.PRO Biopeptide Webstore NPCRIZ

Main » 2020 » February » 08


Dr. Gábor Somlyai, general director and chief scientist of HYD Pharma and HYD LLC for Cancer Research and Drug Development had a lecture on 12 November at the Oncology Investors’ Conference in New York on the HYD group, on research results in deuterium depletion, as well as on the potential therapeutic applications of the procedure and the pharmaceutical development based on that.

The conference was organized with the support of the American National Foundation for Cancer Research (NFCR) on 12-13 November. Its aim was to generate connections between venture capital investors in life sciences and oncology, top managers of the pharma industry, and representatives of oncological startup companies and anticancer foundations, so they can discuss possibilities of investment into oncological research a ... Read more »

Attachments: Image 1
Category: News | Views: 1250 | Added by: GinoBig | Date: 08.02.2020